PubMed=8689637; DOI=10.1016/0304-3835(96)04274-7
Ashok A. Jagasia, Joel A. Block, Abid Qureshi, Manuel O. Diaz, Tsutomu Nobori, Steven Gitelis, Anand P. Iyer;
Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.
Cancer Lett. 105:91-103(1996)

PubMed=10632461; DOI=10.1002/jor.1100170619
James J. Wyman, Abby M. Hornstein, Patricia A. Meitner, Solida Mak, Patrick Verdier, Joel A. Block, J. Pan, Richard M. Terek;
Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance.
J. Orthop. Res. 17:935-940(1999)

PubMed=10906887; DOI=10.1097/00003086-200007000-00038
Sean P. Scully, Keith R. Berend, Alison Toth, Wen-Ning Qi, Zhou Qi, Joel A. Block;
Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma.
Clin. Orthop. Relat. Res. 376:291-303(2000)

PubMed=11854598; DOI=10.1097/00019606-200203000-00005
Chu-Zhao Lin, Patricia A. Meitner, Richard M. Terek;
PTEN mutation is rare in chondrosarcoma.
Diagn. Mol. Pathol. 11:22-26(2002)

PubMed=12168675; DOI=10.1016/S0736-0266(01)00172-3
Michelle Aileen Ghert, Wen-Ning Qi, Harold Paul Erickson, Joel A. Block, Sean P. Scully;
Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells.
J. Orthop. Res. 20:834-841(2002)

PubMed=12354749
James A. Martin, Erin Forest, Joel A. Block, Aloysius J. Klingelhutz, Brent Whited, Steven Gitelis, Andrew Wilkey, Joseph A. Buckwalter;
Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.
Cell Growth Differ. 13:397-407(2002)

PubMed=15547702; DOI=10.3892/ijo.25.6.1651
Cornelius M. Schorle, Irmgard Verdorfer, Florian Finger, Joel A. Block, Erich Gebhart, Thomas Aigner;
Comparative analysis of imbalances in genomic DNA and mRNA expression levels in chondrosarcoma-derived cell line FSCP-1.
Int. J. Oncol. 25:1651-1660(2004)